Oriel Therapeutics Report issue

For profit Phase 1
Founded: Tarboro NC United States (2001)
Status: Acquired by Sandoz (2010) → now Novartis (1996)

Organization Overview

First Clinical Trial
2014
NCT02260492
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (2)

fluticasone (cutivate) (1 trial)

salmeterol (serevent) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2